Latest News & Features
Americas
Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel. 2 July 2020
Biotechnology
The EPO’s May 2020 decision in G3/19, on the patentability of certain plants, was among the most controversial in the office’s history. Anna Gregson of Mathys & Squire explores the implications. 2 July 2020
Generics
Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice. 2 July 2020
Big Pharma
Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici. 1 July 2020
Americas
Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux. 30 June 2020
article
On May 12, 2020, the United Nations Technology Bank, together with the UN Development Programme, UN Conference on Trade and Development and the World Health Organization, launched the Tech Access Partnership as part of a coordinated approach to strengthen developing countries’ responses to COVID-19 and increase access to lifesaving health technologies. 30 June 2020
Americas
Johnson & Johnson has accused a medical supplier of distributing counterfeit surgical tools that are “bacterially contaminated and critically defective”. 29 June 2020
Big Pharma
The executive director of the Medicines Patent Pool says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be. 26 June 2020
Big Pharma
The English Court of Appeal has rejected Neurim’s attempt to block sales of a generic version of its insomnia drug made by Mylan ahead of a patent infringement trial. 26 June 2020
Americas
Latham & Watkins has added two life sciences-focused litigators, Arlene Chow and Ernest Yakob, to its New York office. 25 June 2020